Bio Implants

Bio Implants Market Outlook

The global bio implants market is poised for significant growth, projected to reach approximately USD 153 billion by 2035, expanding at a robust CAGR of 10.5% between 2025 to 2035. This growth is driven by the increasing prevalence of chronic diseases, rising geriatric population, and a heightened focus on advanced healthcare technologies that enhance the quality of life. Additionally, innovations in materials science and the development of biocompatible implant materials are fueling market advancements, making bio implants more effective and safer for patients. Furthermore, the surge in surgical procedures and the expanding applications of bio implants across various medical fields are propelling market expansion. As healthcare systems increasingly adopt minimally invasive techniques, the demand for bio implants is expected to rise significantly, contributing to a favorable market outlook.

Growth Factor of the Market

The growth of the bio implants market can be attributed to several key factors, including technological advancements in implant designs and materials, which have improved patient outcomes and reduced recovery times. The rising awareness among healthcare providers and patients about the benefits of bio implants is also contributing to market growth, particularly in developing regions facing a high burden of chronic diseases. Furthermore, an increase in government initiatives to promote research and development in the medical device sector is expected to enhance innovation and product availability. The growing trend of personalized medicine, where treatments and implants are tailored to individual patient needs, is further catalyzing demand. Additionally, the expansion of healthcare infrastructure in emerging economies is likely to provide significant opportunities for market players, enhancing accessibility and affordability of bio implant solutions.

Key Highlights of the Market

• Projected market size of USD 153 billion by 2035 with a CAGR of 10.5% from 2025 to 2035.
• Technological advancements in bio implant materials and designs enhancing patient outcomes.
• Increased prevalence of chronic diseases driving demand for orthopedic, dental, and cardiovascular implants.
• Expansion of healthcare infrastructure in emerging markets enhancing accessibility to bio implants.
• Growing trend of personalized medicine tailored to individual patient needs.

By Product Type

Orthopedic Implants:

Orthopedic implants constitute a significant segment of the bio implants market, primarily designed to support or replace damaged bone structures. These implants include screws, plates, rods, and joint replacements that aid in the restoration of mobility and functionality in patients suffering from fractures or degenerative conditions. The increasing incidence of orthopedic disorders, such as osteoarthritis and osteoporosis, driven by an aging population and lifestyle-related factors, is significantly propelling this segment. Furthermore, advancements in materials such as titanium and polymers that provide better biocompatibility and mechanical strength are enhancing the performance of orthopedic implants, thus increasing their adoption in clinical practice.

Dental Implants:

Dental implants are rapidly gaining traction within the bio implants market due to the growing prevalence of dental diseases and the increasing demand for aesthetic dentistry. These implants serve as a permanent solution for tooth loss, providing a durable and aesthetically pleasing alternative to traditional dentures. The rise in oral health awareness and advancements in dental technology, including minimally invasive procedures, are contributing to the growth of this segment. Moreover, the increasing popularity of cosmetic dentistry and the availability of advanced materials that mimic natural tooth appearance are further augmenting the dental implant market, leading to improved patient satisfaction and outcomes.

Cardiovascular Implants:

Cardiovascular implants, including stents, pacemakers, and heart valves, play a critical role in managing various heart-related disorders. The growing prevalence of cardiovascular diseases, attributed to an increase in sedentary lifestyles and chronic conditions like diabetes and hypertension, is significantly driving the demand for these implants. Technological advancements, such as the development of bioresorbable stents and improved materials that reduce the risk of thrombosis, are enhancing the efficacy and safety of cardiovascular implants. Additionally, the increasing focus on preventative healthcare and timely interventions is propelling the adoption of cardiovascular implants among patients, which is expected to significantly boost this segment's growth.

Ophthalmic Implants:

Ophthalmic implants, such as intraocular lenses and retinal implants, are essential for treating various eye disorders, including cataracts and retinal diseases. The rising incidence of visual impairments, driven by the aging population and lifestyle factors such as prolonged screen exposure, is contributing to the growth of the ophthalmic implants market. Innovations in materials and designs that enhance lens compatibility and reduce the risk of complications are propelling the adoption of these implants. Furthermore, the increasing prevalence of eye surgeries, supported by advancements in surgical techniques and technologies, is likely to boost the demand for ophthalmic implants, making them an integral part of the bio implants market.

Neurostimulator Implants:

Neurostimulator implants are increasingly recognized for their effectiveness in managing neurological disorders such as Parkinson's disease, epilepsy, and chronic pain. These implants work by delivering electrical impulses to specific areas of the nervous system, providing significant relief to patients who have not responded well to traditional therapies. The growing awareness and acceptance of neurostimulation therapies, coupled with technological advancements that allow for more precise and targeted stimulation, are driving the growth of this segment. Moreover, the rising incidence of neurological disorders, supported by an increase in research and development initiatives focused on brain-computer interfaces and neuroprosthetics, are expected to propel further market growth in the neurostimulator segment.

By Application

Orthopedic:

The orthopedic application segment of the bio implants market is driven by the increasing prevalence of musculoskeletal disorders and the aging population. Orthopedic implants are utilized in various procedures, including joint replacements, fracture fixation, and spinal stabilization, aimed at restoring mobility and alleviating pain. The growing trend towards minimally invasive surgical techniques is also enhancing the adoption of orthopedic implants, as these methods often lead to shorter recovery times and improved patient experiences. Furthermore, ongoing research focused on developing innovative materials and designs that promote faster healing and better integration with natural bone tissue is expected to bolster this segment's growth significantly.

Dental:

The dental application segment is experiencing rapid growth due to the increasing incidence of dental diseases and the rising demand for cosmetic dental procedures. With advancements in dental implant technology, including the introduction of mini dental implants and immediate loading techniques, patients are now able to achieve quicker and more effective results. This segment is further supported by the emphasis on preventive dental care and the growing number of dental clinics and specialists offering implant services. Additionally, the integration of digital dentistry, such as 3D imaging and computer-assisted implant planning, is enhancing the accuracy and success rates of dental implant procedures, thereby stimulating market growth.

Cardiovascular:

The cardiovascular application segment is primarily driven by the increasing prevalence of heart diseases and conditions requiring surgical interventions. Cardiovascular implants, such as stents and heart valves, play a crucial role in managing these conditions, thus driving demand in this segment. Furthermore, the global increase in lifestyle-related risk factors, including obesity and sedentary behavior, is significantly contributing to the rising incidence of cardiovascular diseases. Innovations in cardiovascular devices that improve patient outcomes, along with growing awareness regarding preventive healthcare measures, are propelling the growth of this application segment, making it a key focus area for manufacturers and healthcare providers alike.

Ophthalmic:

The ophthalmic application segment is growing rapidly due to the increasing incidence of visual impairments and the prevalence of age-related eye diseases. As the population ages, the demand for surgical interventions, such as cataract surgeries and retinal repairs, is rising, driving the need for ophthalmic implants. Innovations in intraocular lenses and retinal devices that enhance surgical outcomes and reduce complications are boosting the adoption of these implants. Additionally, the growing emphasis on eye health awareness and advancements in diagnostic and surgical technologies are expected to further accelerate the growth of the ophthalmic application segment within the bio implants market.

Neurology:

The neurology application segment is propelled by the rising prevalence of neurological disorders and the increasing acceptance of neurostimulation therapies. Neurostimulator implants are used to manage conditions such as chronic pain, movement disorders, and epilepsy, contributing to an increased demand for these devices. The advancements in neurotechnology, including the development of closed-loop systems that adapt to patient needs in real-time, are enhancing the efficacy and safety of these implants. Furthermore, ongoing research and clinical trials focused on new applications for neurostimulators are likely to expand their use, driving significant growth in this segment in the coming years.

By Distribution Channel

Hospitals:

The hospital distribution channel is a critical segment in the bio implants market, as hospitals account for a substantial portion of implant procedures. Hospitals provide a comprehensive platform for patient care, including pre-operative assessments, surgical interventions, and post-operative management, making them a primary choice for implant procedures. The increasing number of hospital admissions for chronic diseases and elective surgeries is driving the demand for bio implants within this channel. Additionally, hospitals often have partnerships with leading implant manufacturers, ensuring access to advanced technologies and a diverse range of implant options for patients.

Specialty Clinics:

Specialty clinics have emerged as a prominent distribution channel for bio implants, providing specialized care for specific conditions such as orthopedic, dental, and cardiovascular disorders. These clinics often focus on minimally invasive procedures and patient-centered care, which enhances patient satisfaction and outcomes. The increasing number of specialty clinics and their growing popularity among patients seeking focused treatments is significantly contributing to the growth of this segment. Moreover, the collaboration between specialty clinics and manufacturers to offer advanced and customized implant solutions is further augmenting market growth within this distribution channel.

Online Stores:

The online stores distribution channel is gaining traction in the bio implants market, primarily driven by the increasing adoption of e-commerce in the healthcare sector. Patients and healthcare providers are increasingly turning to online platforms for purchasing medical devices, including bio implants, due to the convenience and accessibility they offer. This trend is further supported by advancements in telemedicine and remote patient monitoring, which facilitate online consultations and assessments. Additionally, the growing focus on patient empowerment and informed decision-making is leading to an increase in the availability of medical information and implant options through online channels.

Direct Sales:

Direct sales remain a significant distribution channel for bio implants, allowing manufacturers to engage directly with healthcare providers and patients. This channel provides a unique opportunity for manufacturers to showcase their products and educate healthcare professionals on the benefits and applications of their implants. The direct sales approach often leads to stronger relationships between manufacturers and healthcare providers, fostering collaboration and ensuring that patients receive the most suitable implant options for their needs. As the market evolves, direct sales strategies are becoming increasingly critical for manufacturers aiming to maintain a competitive edge and drive product adoption.

By Material Type

Metallic Implants:

Metallic implants are traditionally the most commonly used bio implants due to their excellent mechanical properties, strength, and biocompatibility. Materials such as titanium and stainless steel are widely utilized in various applications, including orthopedic and cardiovascular implants. The durability and resistance to corrosion of metallic implants make them suitable for long-term use, ensuring patient safety and satisfaction. Furthermore, ongoing advancements in surface treatment technologies are enhancing the integration of metallic implants with surrounding biological tissues, thereby improving clinical outcomes and driving the growth of this segment.

Ceramic Implants:

Ceramic implants are gaining popularity in the bio implants market due to their excellent biocompatibility and aesthetic appeal. These implants are primarily utilized in dental applications, where the natural appearance of ceramic materials closely resembles that of natural teeth. The increasing demand for cosmetic dentistry and the rise in dental procedures are significantly driving the market for ceramic implants. Additionally, advancements in manufacturing techniques and the development of bioactive ceramics that promote bone integration are further enhancing the adoption of ceramic implants in various medical applications.

Polymer Implants:

Polymer implants are becoming increasingly relevant in the bio implants market due to their versatility and favorable properties. These implants, often made from biocompatible materials such as polyethylene and polycaprolactone, are used in various applications, including orthopedic and soft tissue repairs. The lightweight nature and flexibility of polymer implants make them an attractive option for many surgical procedures. Additionally, ongoing research focused on developing smart polymers that can respond to environmental stimuli is expected to drive innovation in this segment, enhancing the functionality and effectiveness of polymer implants in the future.

Natural Implants:

Natural implants, derived from biological tissues, are gaining traction in the bio implants market due to their inherent biocompatibility and ability to mimic the structure of natural tissues. These implants are often used in applications such as tissue engineering and regenerative medicine, where the goal is to restore or replace damaged tissues. The increasing emphasis on developing sustainable and biologically-derived solutions is propelling the growth of natural implants, as they align with the trend towards environmentally friendly practices in healthcare. Furthermore, advancements in processing techniques that enhance the safety and effectiveness of natural implants are expected to drive their adoption in clinical settings.

By Region

The bio implants market is witnessing significant growth in North America, primarily driven by the increasing prevalence of chronic diseases and advancements in medical technology. The region is home to several leading manufacturers and research institutions, which are continuously innovating to improve bio implant designs and materials. With a robust healthcare infrastructure and high healthcare expenditure, North America accounts for a considerable share of the global bio implants market. The increasing adoption of minimally invasive surgeries and advancements in implant technologies are further propelling market growth in this region, contributing to a projected CAGR of 11.0% over the forecast period.

Europe is also experiencing substantial growth in the bio implants market, driven by a growing elderly population and a high prevalence of orthopedic and cardiovascular diseases. The European region is characterized by a strong focus on research and development, with various government initiatives aimed at promoting innovation in medical devices. Additionally, the increasing collaboration between industry stakeholders and research institutions is expected to bolster the development of advanced bio implant technologies. As a result, Europe holds a significant share of the global market and is projected to witness a steady growth rate during the forecast period.

Opportunities

The bio implants market presents numerous opportunities for growth, particularly in developing regions where advancements in healthcare infrastructure are underway. As emerging economies continue to invest in healthcare, the demand for bio implants is expected to rise significantly. The growing awareness of preventive healthcare and the need for effective treatments for chronic diseases are driving the adoption of bio implants in these regions. Moreover, the increasing prevalence of lifestyle-related disorders, coupled with an aging population, is creating a favorable environment for market expansion. Manufacturers can capitalize on these trends by expanding their distribution networks and establishing partnerships with local healthcare providers to enhance accessibility to their products.

Another significant opportunity lies in the ongoing advancements in technology and materials used for bio implants. With continuous research focused on developing innovative solutions that improve patient outcomes, manufacturers have the potential to introduce groundbreaking products into the market. The rise of personalized medicine, where treatments are tailored to individual patient needs, offers an additional avenue for growth. By leveraging new technologies such as 3D printing and smart materials, companies can create customized implants that meet specific patient requirements, thereby enhancing their competitive advantage in the market. This focus on innovation and customization is expected to drive substantial growth opportunities in the bio implants sector.

Threats

Despite the promising growth prospects for the bio implants market, several threats could impede its progress. The increasing regulatory scrutiny surrounding medical devices poses a significant challenge for manufacturers, as compliance with stringent regulations can lead to delays in product launches and increased operational costs. Additionally, the presence of counterfeit products in the market can undermine consumer confidence and jeopardize patient safety. The rapid pace of technological advancements also means that companies must continuously invest in research and development to stay competitive, which can strain financial resources, particularly for smaller players in the market. Lastly, the global economic uncertainties and fluctuations in healthcare expenditure can impact the overall demand for bio implants, posing a potential threat to market growth.

Restraining factors such as high costs associated with bio implants can also act as barriers to market growth. Many patients may find it difficult to afford advanced implant treatments, particularly in developing countries with limited healthcare budgets. Additionally, the lack of reimbursement policies for certain bio implants can further deter patients from opting for these solutions, leading to a decline in market demand. Manufacturers need to navigate these challenges effectively by exploring cost-reduction strategies and advocating for favorable reimbursement policies to ensure the sustainability and growth of the bio implants market.

Competitor Outlook

• Stryker Corporation
• Medtronic plc
• Zimmer Biomet Holdings, Inc.
• Johnson & Johnson Services, Inc.
• Smith & Nephew plc
• Boston Scientific Corporation
• NuVasive, Inc.
• DePuy Synthes (a subsidiary of Johnson & Johnson)
• Osstem Implant Co., Ltd.
• Invuity, Inc.
• Abbott Laboratories
• Implant Innovations, Inc.
• Biometrix, Inc.
• MicroPort Scientific Corporation
• Heraeus Medical GmbH

The competitive landscape of the bio implants market is characterized by a diverse range of players, ranging from established global companies to emerging startups specializing in innovative implant technologies. The market is highly fragmented, with leading firms focusing on strategic initiatives such as mergers and acquisitions, partnerships, and collaborations to enhance their product offerings and expand their market presence. Companies are increasingly investing in research and development to introduce advanced bio implant solutions that address specific patient needs and improve overall outcomes. Furthermore, the growing trend of personalized medicine is driving competition, with manufacturers striving to develop customized implants tailored to individual patient profiles.

Major players such as Stryker Corporation and Medtronic plc are at the forefront of the bio implants market, leveraging their extensive experience and resources to deliver high-quality products. Stryker is known for its innovative orthopedic implants, including joint replacement systems, while Medtronic is recognized for its advanced cardiovascular devices. Both companies are committed to enhancing patient care through continuous innovation and strategic collaborations with healthcare professionals. Moreover, they are actively involved in research initiatives aimed at developing next-generation bio implants that improve functionality and patient satisfaction.

Other notable companies, such as Zimmer Biomet Holdings, Johnson & Johnson Services, and Smith & Nephew, are also significant players in the bio implants market. Zimmer Biomet specializes in orthopedic implants and is known for its strong portfolio of joint replacement products. Johnson & Johnson Services, through its DePuy Synthes subsidiary, offers a comprehensive range of surgical solutions, including implants for various applications. Smith & Nephew is recognized for its advanced wound care and orthopedic products, focusing on enhancing patient outcomes through innovative technologies. Collectively, these key players are driving the evolution of the bio implants market by introducing cutting-edge solutions that meet the growing demands of healthcare providers and patients alike.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Invuity, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 NuVasive, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Biometrix, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smith & Nephew plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Stryker Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Heraeus Medical GmbH
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Osstem Implant Co., Ltd.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Implant Innovations, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Zimmer Biomet Holdings, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Boston Scientific Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Johnson & Johnson Services, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 MicroPort Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 DePuy Synthes (a subsidiary of Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bio Implants Market, By Application
    • 6.1.1 Orthopedic
    • 6.1.2 Dental
    • 6.1.3 Cardiovascular
    • 6.1.4 Ophthalmic
    • 6.1.5 Neurology
  • 6.2 Bio Implants Market, By Product Type
    • 6.2.1 Orthopedic Implants
    • 6.2.2 Dental Implants
    • 6.2.3 Cardiovascular Implants
    • 6.2.4 Ophthalmic Implants
    • 6.2.5 Neurostimulator Implants
  • 6.3 Bio Implants Market, By Material Type
    • 6.3.1 Metallic Implants
    • 6.3.2 Ceramic Implants
    • 6.3.3 Polymer Implants
    • 6.3.4 Natural Implants
    • 6.3.5 Others
  • 6.4 Bio Implants Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Online Stores
    • 6.4.4 Direct Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Bio Implants Market by Region
  • 10.3 Asia Pacific - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 India
      • 10.3.1.2 China
      • 10.3.1.3 Japan
      • 10.3.1.4 South Korea
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bio Implants market is categorized based on

By Product Type

• Orthopedic Implants
• Dental Implants
• Cardiovascular Implants
• Ophthalmic Implants
• Neurostimulator Implants

By Application

• Orthopedic
• Dental
• Cardiovascular
• Ophthalmic
• Neurology

By Distribution Channel

• Hospitals
• Specialty Clinics
• Online Stores
• Direct Sales

By Material Type

• Metallic Implants
• Ceramic Implants
• Polymer Implants
• Natural Implants
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Stryker Corporation
• Medtronic plc
• Zimmer Biomet Holdings, Inc.
• Johnson & Johnson Services, Inc.
• Smith & Nephew plc
• Boston Scientific Corporation
• NuVasive, Inc.
• DePuy Synthes (a subsidiary of Johnson & Johnson)
• Osstem Implant Co., Ltd.
• Invuity, Inc.
• Abbott Laboratories
• Implant Innovations, Inc.
• Biometrix, Inc.
• MicroPort Scientific Corporation
• Heraeus Medical GmbH